Immage Biotherapeutics Corp.
IMMG
$0.00
$0.000.00%
OTC PK
| 02/28/2017 | 11/30/2016 | 08/31/2016 | 05/31/2016 | 02/29/2016 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 45.12% | 98.33% | 161.33% | 452.90% | 663.40% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1,106.53% | 2,114.34% | 267.46% | 624.71% | 890.20% |
| Operating Income | -1,106.53% | -2,114.34% | -267.46% | -624.71% | -890.20% |
| Income Before Tax | -1,100.20% | -2,093.37% | -268.82% | -627.80% | -895.42% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1,100.20% | -2,093.37% | -268.82% | -627.80% | -895.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,100.20% | -2,093.37% | -268.82% | -627.80% | -895.42% |
| EBIT | -1,106.53% | -2,114.34% | -267.46% | -624.71% | -890.20% |
| EBITDA | -1,278.48% | -2,751.47% | -512.72% | -- | -- |
| EPS Basic | -1,009.09% | -1,966.67% | -180.00% | -550.00% | -1,000.00% |
| Normalized Basic EPS | -1,000.00% | -1,850.00% | -125.00% | -300.00% | -600.00% |
| EPS Diluted | -1,009.09% | -1,966.67% | -180.00% | -550.00% | -1,000.00% |
| Normalized Diluted EPS | -1,000.00% | -1,850.00% | -125.00% | -300.00% | -600.00% |
| Average Basic Shares Outstanding | 20.09% | 30.01% | 42.46% | 35.19% | -70.96% |
| Average Diluted Shares Outstanding | 20.09% | 30.01% | 42.46% | 35.19% | -70.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |